Methynodiol diacetate (USAN ) (developmental code name SC-19198), or metynodiol diacetate, also known as 11β-methyletynodiol diacetate, is a steroidal progestin of the 19-nortestosterone group which was patented in 1968 but was never marketed.[1] It is the diacetate ester of metynodiol, which, similarly, was never marketed.[1]
Clinical data | |
---|---|
Other names | Metynodiol diacetate; SC-19198; 11β-Methyletynodiol diacetate; 11β-Methyl-19-norpregn-4-en-20-yne-3β,17α-diyl diacetate; 11β-Methyl-17α-ethynylestr-4-ene-3β,17β-diol diacetate |
Drug class | Progestogen; Progestogen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C25H34O4 |
Molar mass | 398.543 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 820–. ISBN 978-1-4757-2085-3.